A day after a highly successful Winter Gathering, the RIS Board met for its annual meeting which closed out a very successful 2016 and initiated major plans for this year.
Tom Dougherty reported that the organization grew by almost 30% in 2016 furthering our mission and allowing us to make significant strategic decisions for 2017. The Board approved $125,000 in new Sarcoma research grants at the University of Minnesota that will soon be made public. Funding of the RIS Sarcoma Scholars at both at the University of Minnesota and Mayo Medical Schools was recommitted for the 2017-2018 academic year. In addition, the Board approved a second 2017 Research Funding grant round for later this year that will focus on additional research institutions.
The Board thanked Katie Dusenbery, MD for being a charter Board member having served on the Board and providing key leadership since RIS was created in 2001. Five new members joined our Board and two are continuing for an additional three-year term (related article).
Talent and Resources Committee made a recommendation to move ahead with the hiring of a RIS Executive Director, which was approved by the Board and will most likely take place during the second quarter of this year.